STAT3 and neuroblastoma: In this analysis, we employed CLB-GE, CLB-BAR, Kelly and CLB-GA neuroblastoma cell lines, measuring their growth in response to treatment with the STAT3 inhibitor FLLL32 or STAT3 siRNA.